altRx vs MEDVi: The Lower Price or the Fuller Program?
Both run promo pricing on compounded GLP-1s - one strips it back, the other adds a dietitian and coaching
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Reviewed · Written by The Top Weight Loss Editorial Team · How we review
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The verdict
9.3/10 vs 8.7/10
altRx is the stronger pick for most people - $89/mo semaglutide, $149/mo tirzepatide (promo). Full reasoning, pricing and the cases where MEDVi wins are below.
| At a glance | altRx | MEDVi |
|---|---|---|
| Starting price | $89/mo (promo) | $99/mo (promo) |
| Medications | Compounded sema & tirz + brand-name | Compounded semaglutide & tirzepatide |
| Prescription | Required - online provider review | Required - online provider review |
| Delivery | Free, 5-7 days | Free |
Prices are the providers’ published rates at our last verification - confirm the final figure at checkout, as offers change. How we verify prices
One flat price at every dose for compounded GLP-1s, plus a brand-name shelf in the same account
- Semaglutide $89/mo, tirzepatide $149/mo (promo)
- Same price at every dose
- Brand-name Wegovy, Zepbound & Ozempic available
All-inclusive compounded GLP-1 care - clinician visits, dietitian access and coaching bundled into one monthly price
- Semaglutide $99/mo, tirzepatide $166/mo (promo)
- Clinician visits, dietitian & coaching included
- No membership or hidden fees
The full breakdown
altRx vs MEDVi: a closer look at each
Both are credible providers in this category, and the right pick comes down to fit. So instead of crowning a “winner,” here’s the real rundown on each - what you get, what it actually costs, and what real customers are saying - so you can pick the one that fits you.
What is altRx?
altRx sells compounded semaglutide and tirzepatide at one flat price regardless of dose, which matters because many programs charge more as your dose climbs. It also offers brand-name Ozempic, Zepbound and Wegovy at self-pay list prices in the same account, so you can switch without changing providers.
Read the full altRx breakdown▾
The intake is fast and asynchronous, with video when needed and a tracking app. One thing every reader should know before signing up: on June 8, 2026 the FDA issued a warning letter to altRx's parent company, Trinity HealthCare Supply, LLC (dba altRx), because, in the agency's view, its marketing and labels made its compounded semaglutide and tirzepatide look FDA-approved.
Compounded GLP-1s are not FDA-approved. This review covers altRx's pricing, how it works and how to weigh that letter.
What you get with altRx
- Compounded semaglutide $89/month and tirzepatide $149/month (promo rates)
- Flat price at every dose - no increase as you titrate up
- Brand-name shelf: Ozempic, Zepbound and Wegovy at self-pay list prices
- No commitment - pause or cancel anytime; Buy Now, Pay Later available
- Fast async intake, video when needed, tracking app
- Free shipping, arrives in 5-7 days
Who altRx is best for
- People who expect to reach higher doses and want one flat price throughout
- Those who want compounded and brand-name options under one provider
- Skip it if an FDA warning letter is a deal-breaker for you, or if you need medication fast - embody ships in 1-2 days
How much does altRx cost?
altRx charges one flat price at every dose: compounded semaglutide is $89/month on promo (regular $199) and compounded tirzepatide is $149/month on promo (regular $299).
Full pricing details▾
Promo rates are time-limited - after the promotion you pay the regular price, which is well above most competitors, so check which rate applies to you. Brand-name medication is also available at self-pay list prices: Ozempic $1,149/month, Zepbound $1,249/month and Wegovy $1,579/month.
Shipping is free and there is no commitment. Note that altRx received an FDA warning letter dated June 8, 2026 about how it marketed its compounded products, and compounded GLP-1s are not FDA-approved.
Semaglutide
Compounded semaglutide
Promo rate, time-limited - no commitment
- Same price at every dose
- Free shipping (5-7 days)
- Buy Now, Pay Later
Tirzepatide
Compounded tirzepatide
Promo rate, time-limited - no commitment
- Same price at every dose
- Pause or cancel anytime
- Tracking app
Brand-name shelf
Ozempic / Zepbound / Wegovy
Self-pay list prices
- Ozempic $1,149/mo
- Zepbound $1,249/mo
- Wegovy $1,579/mo
What we like about altRx
- Same price at every dose, so costs do not rise as you step up
- Competitive promo pricing: semaglutide $89/month, tirzepatide $149/month
- Brand-name options in the same account if you want to switch
- No commitment, plus Buy Now, Pay Later
Worth keeping in mind
- FDA warning letter (June 8, 2026) to its parent company saying its marketing overstated its compounded GLP-1s and its labels suggested FDA approval
- Compounded medication is not FDA-approved or FDA-reviewed for safety, effectiveness or quality
- Promo prices are time-limited; regular prices ($199 / $299) are among the highest on our list
- Slower delivery than rivals - 5-7 days
- No published Trustpilot rating to cross-check customer experience
What is MEDVi?
MEDVi takes a different approach to pricing from most GLP-1 telehealth brands: instead of a low medication price with add-ons, it bundles everything into one monthly figure. Clinician visits, access to a dietitian and coaching are all included, shipping is free, and there is no separate membership or hidden fee.
Read the full MEDVi breakdown▾
Plans carry no commitment and HSA/FSA funds are accepted. Licensed US clinicians handle prescribing, and brand-name options are available through your clinician if compounded medication is not the right fit.
It also has one of the largest review bases on our list - 4.3 / 5 from 14,978 Trustpilot reviews. As with every compounded program, the medication is not FDA-approved.
This review covers what MEDVi costs, what the bundle includes and who it suits.
What you get with MEDVi
- Compounded semaglutide $99/month and tirzepatide $166/month (promo rates)
- All-inclusive: clinician visits, dietitian access and coaching in the price
- No membership fee and no hidden fees
- No commitment; HSA/FSA accepted
- Licensed US clinicians; brand-name options via your clinician
- Free shipping
Who MEDVi is best for
- People who want nutrition and coaching support bundled with their medication
- Anyone who wants one predictable price with no membership or add-on fees
- Those who value a large, well-rated customer base
- Skip it if you only want the medication at the lowest price - embody and wellmedr cost less
How much does MEDVi cost?
MEDVi charges one all-inclusive monthly price: compounded semaglutide is $99/month on promo (regular $199) and compounded tirzepatide is $166/month on promo (regular $299).
Full pricing details▾
Clinician visits, dietitian access, coaching and shipping are included, with no membership or hidden fees and no commitment. HSA/FSA funds are accepted.
The promo rates are time-limited - after the promotion the regular prices are among the highest on our list, so confirm which rate applies at checkout. Brand-name options are available through your clinician at separate pricing.
Compounded GLP-1s are not FDA-approved.
Semaglutide
Compounded semaglutide
Promo rate - no commitment
- Clinician visits included
- Dietitian access & coaching
- No membership or hidden fees
Tirzepatide
Compounded tirzepatide
Promo rate - no commitment
- All-inclusive price
- Free shipping
- HSA/FSA accepted
What we like about MEDVi
- Genuinely all-inclusive - clinician visits, dietitian access and coaching in one price
- No membership or hidden fees, and no commitment
- Strong customer feedback at scale (4.3 / 5 from 14,978 Trustpilot reviews)
- Brand-name options available through the same clinician
- HSA/FSA accepted, free shipping
Worth keeping in mind
- Higher promo prices than embody or wellmedr - $99 semaglutide and $166 tirzepatide
- Regular prices ($199 / $299) are steep once the promotion ends
- Compounded medication is not FDA-approved or FDA-reviewed for safety, effectiveness or quality
- If you do not need coaching or a dietitian, you are paying for support you will not use
What real MEDVi customers are saying
MEDVi reviews on
TrustpilotI luv how they keep up with my health...
“I luv how they keep up with my health and well-being. I've had nothing but great experience with all I've spoken with.”
Deborah Thompson
US
5-star experience
“The provider, Monique, was very personable, professional and helpful.”
Gigi
US
Nestor was patient and answered all my...
“Nestor was patient and answered all my questions thoroughly.”
Heidi
US
Responding to MEDVi
“I don’t want to send a review. I jsit wanted to compliment my medical person to MEDVi.”
Wendy Nickels
US
altRx vs. MEDVi: What’s the Difference?
The key differences to consider when comparing the two providers.
| altRx | MEDVi | |
|---|---|---|
| Starting price | $89/mo (promo) | $99/mo (promo) |
| Medications | Compounded sema & tirz + brand-name | Compounded semaglutide & tirzepatide |
| Semaglutide | $89/mo promo (reg. $199) | $99/mo promo (reg. $199) |
| Tirzepatide | $149/mo promo (reg. $299) | $166/mo promo (reg. $299) |
| Dietitian & coaching | Not included | Included |
| Shipping | Free, 5-7 days | Free |
| Commitment | None - pause or cancel | None - no membership |
| Trustpilot | No Trustpilot profile | 4.3/5 (14,978) |
| Payment | Buy Now, Pay Later | HSA/FSA accepted |
So which one should you pick?
Find the line that sounds like you - that’s your answer.
Here’s the short version
altRx and MEDVi sit close together on price, and both lean on promotional rates, so the headline numbers only tell part of the story. altRx is the lean option: flat pricing at every dose, a brand-name shelf and Buy Now, Pay Later. MEDVi charges about $10-$17 a month more at promo prices and spends it on people - clinician visits, a dietitian and coaching are in the price.
There is also a trust gap to weigh: altRx's parent company received an FDA warning letter in June 2026.
The quick answer
Go with altRx if you want
- $89/mo semaglutide, $149/mo tirzepatide (promo)
- Flat price at every dose
- Brand-name shelf and Buy Now, Pay Later
MEDVi makes more sense if you want
- Dietitian access and coaching included
- 4.3/5 on Trustpilot from 14,978 reviews
- No FDA warning letter
Had to pick one for most people? altRx. The numbers and customer feedback below are why - and where MEDVi wins instead.
MEDVi vs altRx: FAQs
Which is better, MEDVi vs altRx?
altRx edges it on price: $89/mo semaglutide and $149/mo tirzepatide at every dose (promo; regular $199 and $299), with brand-name medication on the same shelf if you switch later. MEDVi is the better program if you want support that goes beyond the prescription - its dietitian and coaching are included for $99 or $166 a month (promo; regular $199 and $299) - and it has a clean regulatory record and a 4.3/5 Trustpilot score from 14,978 reviews. At regular prices the two cost the same, which makes MEDVi's extras free. Ask both how long their promos last. Compounded medications are not FDA-approved, and a licensed clinician decides what is right for you.
Is altRx cheaper than MEDVi?
At promo prices altRx is $10/mo cheaper on semaglutide ($89 vs $99) and $17/mo cheaper on tirzepatide ($149 vs $166). At regular prices they match exactly - $199 and $299 - so the gap only exists while the promos run.
Which has better medical support, altRx or MEDVi?
MEDVi includes clinician visits, a dietitian and coaching in the monthly price. altRx runs a fast async intake with video when needed and a tracking app, but no nutrition coaching.
Which has more medication options, altRx or MEDVi?
Both prescribe compounded semaglutide and tirzepatide. altRx also publishes a brand-name shelf - Ozempic $1,149, Zepbound $1,249 and Wegovy $1,579 a month, self-pay - so switching to an FDA-approved drug is one click away.
Which is more transparent about pricing, altRx or MEDVi?
In June 2026 the FDA sent altRx's parent company, Trinity HealthCare Supply, LLC, a warning letter objecting to claims and labels that made its compounded GLP-1s look FDA-approved. MEDVi has no comparable action on record and a 4.3/5 Trustpilot score from 14,978 reviews; altRx has no Trustpilot profile.
Which offers more flexible plans, altRx or MEDVi?
Neither requires a commitment. altRx lets you pause and offers Buy Now, Pay Later; MEDVi has no membership fee and accepts HSA/FSA.
Related Comparisons
Sources & methodology
We built this comparison of altRx and MEDVi from each provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 2.FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize - U.S. Food & Drug Administration
- 3.Wegovy (semaglutide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 4.Zepbound (tirzepatide) injection - prescribing information - U.S. Food & Drug Administration (Drugs@FDA)
- 5.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) - Wilding et al. - New England Journal of Medicine, 2021;384:989-1002
- 6.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) - Jastreboff et al. - New England Journal of Medicine, 2022;387:205-216
- 7.Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) - Aronne et al. - New England Journal of Medicine, 2025
- 8.Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension - Wilding et al. - Diabetes, Obesity and Metabolism, 2022
- 9.Prescription Medications to Treat Overweight & Obesity - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.